Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1336 Cancer vaccine co-targeting PRAME and PD-L1 exerts significant tumor growth inhibition in syngeneic mouse hepatocellular carcinoma models
Compose a Response to This Article
Other responses
No responses have been published for this article.
